The SARS-CoV-2 Antigen Self Test Nasal provides reliable results for individuals suspected of having COVID-19. The Self Test can be performed by lay users, providing another option for decentralized testing. Testing whenever and wherever needed can be the basis for faster decision making and a step towards returning to normality for everyone.
Simple to perform and fast results in 15 to 30 minutes*
Insert the swab into one nostril. Slowly slide it approx. 2 cm forward. Rotate the swab 4 times (for approx. 15 seconds) against the lining of the nasal wall, before removing it. Repeat in other nostril using the same swab.
Insert the swab into an extraction buffer tube, squeeze the tube and stir the swab more than 10 times. Remove the swab while squeezing the sides of the tube. Press the nozzle cap tightly onto the tube.
Add 4 drops of extracted sample vertically into the specimen well of the test device.
Read the test result at 15 to 30 minutes. Do not touch or move the test device until the result can be read.
WARNING! Test results that are read before 15 minutes or after 30 minutes may be incorrect.
WARNING! Failure to squeeze the tube can lead to incorrect results.
*Before using the Sars-Cov-2 Antigen Self Test Nasal, carefully read the Instructions for Use and all included warnings and precautions. Wash your hands or use hand sanitizer before and after performing the test.
Test results are quick and easy to read
If both colored lines C and T are visible, even if they are faint or not uniform, the test result is positive. This means the test detected the virus protein in the sample. The tested person is very likely infected with SARS-CoV-2.
Control line C: Indicates that the test is working correctly
Test line T: visible if SARS-CoV-2 antigen was detected
A visible control line C alone means the test worked correctly. The test result is negative. No virus protein could be detected in the sample. The tested person is unlikely infected with SARS-CoV-2.
If a control line (C) is not visible, or only the line marked with a T, the result must be considered invalid. The test is not working correctly and you should perform another test using a different test kit.
Each kit contains 5 individually packaged, ready-to-use tests.
The following components are needed for a test and are included in the kit:
navify Pass offers a data-management solution which allows allows safe sharing and storing of test-result data for both professional users and test-recipients.
References
This test is an in vitro nucleic acid amplification test for the qualitative detection of Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (NG) in patient specimens.* The test utilizes amplification of target DNA by the Polymerase Chain Reaction (PCR) and nucleic acid hybridization for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae. This test is intended to be used as a diagnostic as well as a screening tool.
*For a list of approved specimen types, please contact your local Roche representative.
*Relative sensitivity and relative specificity are compared to RT-PCR.
